NBDF showcases a wide array of findings from the latest in bleeding disorders research at our annual Bleeding Disorders Conference.

    Surgical Experience in Two Multicenter, Open-label Phase 3 Studies of Emicizumab in Persons with Hemophilia A with Inhibitors (HAVEN 1 and HAVEN 2)

    Surgical Experience in Two Multicenter, Open-label Phase 3 Studies of Emicizumab in Persons with Hemophilia A with Inhibitors (HAVEN 1 and HAVEN 2)

    AWARDED/PRESENTED: 2018
    GRANT/PROGRAM:
    Bleeding Disorders Conference
    Clinical Research/Clinical Trials
    RESEARCHERS:
    Tiffany Chang, Christophe Dhalluin, Guy Young, Johannes Oldenburg, Richard Ko, Liane Khoo, Michael Callaghan, Paul Solari, Rebecca Kruse-Jarres, Michael Recht, Ri Liesner, Stacy Croteau, Tadashi Matsushita, Benjamin Trzaskoma, Victor Yuste, Jin Xu
    Giving men with vwd a voice

    Giving men with vwd a voice

    AWARDED/PRESENTED: 2018
    GRANT/PROGRAM:
    Bleeding Disorders Conference
    Peer Support/Outreach/Integration Models
    RESEARCHERS:
    Felix Olaya, Kate Nammacher
    Discrepant Hemophilia A: Single Institution Experience

    Discrepant Hemophilia A: Single Institution Experience

    AWARDED/PRESENTED: 2018
    GRANT/PROGRAM:
    Bleeding Disorders Conference
    Clinical Research/Clinical Trials
    RESEARCHERS:
    Ahmad Alhuniti, Anjali Sharathkumar, Karla Watkinson, Michelle Krantz, Sharathkumar Bhagavathi, Usha Perepu